| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.39 | 0.0006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |